Merck safety narratives are tradeable only when the regulator moves, not when the internet speculates
The Opportunity
The SHORT call is a classic overhang setup: patient-safety and public-health narratives can turn into label changes, utilisation constraints, litigation, or policy pressure, all of which can compress multiples. But this is already spreading, so the informational edge is fading.
The Timing
INVESTIGATE fits because the key is whether there is an impending, discrete catalyst (regulator communication, label change, formal investigation) that is not fully priced. In Bearish 68 conditions, the tape is receptive to downside narratives, but crosswind risk is high, so you want hard dates and hard artefacts. Without them, this risks becoming a slow bleed with poor timing control.
The Evidence
Hydration failure blocks direct sourcing. 7A keeps the mechanism negative and marks the signal as catalytic with decaying edge. The right next step is to anchor the narrative to an official action; without that, it remains a broad, already-disseminating theme.